HIV

The vaccine that prevents illness and death from pneumococcal infection also combats severe antibiotic-resistant disease in young children.

Provides use, cost forecast based on testing, future treatment rates.

Harvoni is comprised of sofosbuvir, a previously approved HCV drug marketed under the brand name Sovaldi, and a new drug called ledipasvir.

Tobacco users have an increased risk of oral human papillomavirus type 16, a sexually transmitted virus that is strongly associated with cervical cancer.

Virus was undetectable for 3 years before researchers discovered viral reservoirs have not disappeared.

Parents who know about the human papillomavirus are not more likely to get their adolescent daughters vaccinated.

Findings of study provide new options for future vaccine development.

Investigators aim to reduce side effects of therapy with sofosbuvir in children with hepatitis C.

Gilead has refined the pharmacokinetics of tenofovir disoproxil fumarate (TDF), an anchor drug in several single-tablet medications for HIV-1, to create tenofovir alafenamide (TAF). Phase II results indicate superior renal outcomes and equivalent clinical outcomes with TAF versus TDF.

Among HIV-positive patients, concurrent use of medications is associated with nonadherence to antiretroviral therapy.

An experimental single-tablet regimen for treatment-naïve adults infected with HIV demonstrated non-inferiority to an FDA-approved combination pill in achieving undetectable viral load.

Much higher rate of patients in real world discontinuing high priced treatment than during clinical studies.

Study finds tolerance varies between individuals determined by their genes.

Results of a phase 3 trial demonstrate the effectiveness of simeprevir in combination with ribavirin and peginterferon as a treatment for patients coinfected with HIV and HCV.

Data indicates that a simeprevir-based therapy is efficacious in patients with HIV-1/HCV genotype 1 coinfection.

A recent study published in the journal Hepatology indicates that as many as 11% of baby boomers had a positive test result for presence of anti-HCV antibodies.

Study finds HIV suppression reduces hepatitis C viral replication over time.

Following recent analysis, researchers found that infants who received HIV vaccines showed immune response to the vaccine.

Experts at Johns Hopkins say ability to go off antiviral treatment for an extended period of time is a critical goal.

TIM-family proteins may be able to block a wide range of viral infections.

TIM-family proteins may be able to block a wide range of viral infections.

A protein found in nearly half of African Americans speeds removal of medication from the body.

Study suggests pharmacists are more than qualified to navigate outpatients with HIV through treatment options.

Ceasing treatment may be the only way to determine whether HIV is cured, but doing so carries long-term risks.

Study finds that ceasing treatment may be the only way to determine if the disease is cured, but doing so carries long-term risks.